PATHIOS THERAPEUTICS LIMITED
Research and experimental development on biotechnology
PATHIOS THERAPEUTICS LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
99 Park Drive Milton Abingdon OX14 4RY England
Full company profile for PATHIOS THERAPEUTICS LIMITED (10641754), an active life sciences and medical technology company based in Abingdon, England. Incorporated 27 Feb 2017. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2017–2024)
Cash in Bank
£3.25M
Net Assets
£4.85M
Total Liabilities
£677.30k
Turnover
N/A
Employees
7
Debt Ratio
12%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 31 Dec Year End | 2023 31 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
See all 4 grants
Sign up to view complete grant history
Investors (3)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 1 | Dec 2019 | Series B, Series A |
| Investor 2 | Dec 2019 | Series B, Series A |
| Investor 3 | Apr 2024 | Series B |
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Ahrens, Brenton Karl | Director | American | United States | 28 Aug 2019 | Active |
| Mccarthy, Thomas David | Director | Australian | United Kingdom | 27 Feb 2017 | Active |
See all 11 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
Canaan Xi L.p.
Ceased 28 Aug 2019
Someit Singh Sidhu
Ceased 29 Oct 2018
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 22 May 2026 | Capital | Allotment of shares (GBP 478.0675) on 30 Apr 2026 | |
| 1 May 2026 | Capital | Allotment of shares (GBP 460.4582) on 17 Apr 2026 | |
| 12 Mar 2026 | Confirmation Statement | Confirmation statement made on 26 Feb 2026 with updates | |
| 25 Feb 2026 | Capital | Capital Cancellation Shares | |
| 25 Feb 2026 | Capital | Capital Return Purchase Own Shares |
Allotment of shares (GBP 478.0675) on 30 Apr 2026
Allotment of shares (GBP 460.4582) on 17 Apr 2026
Confirmation statement made on 26 Feb 2026 with updates
Capital Cancellation Shares
Capital Return Purchase Own Shares
Recent Activity
Latest Activity
Allotment of shares (GBP 478.0675) on 30 Apr 2026
1 weeks ago on 22 May 2026
Allotment of shares (GBP 460.4582) on 17 Apr 2026
1 months ago on 1 May 2026
Confirmation statement made on 26 Feb 2026 with updates
2 months ago on 12 Mar 2026
Capital Cancellation Shares
3 months ago on 25 Feb 2026
Capital Return Purchase Own Shares
3 months ago on 25 Feb 2026